New antibody therapy targets Hard-to-Treat prostate cancer

NCT ID NCT07529717

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental drug called AZD8359 for men with metastatic prostate cancer that has spread and is no longer responding to standard treatments. The drug is designed to guide the body's immune cells to attack cancer cells. The trial will first find the safest dose and then test it in a larger group to see if it can shrink tumors or lower PSA levels.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic prostate carcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    RECRUITING

    Orlando, Florida, 32806, United States

  • Research Site

    NOT_YET_RECRUITING

    East Brunswick, New Jersey, 08816, United States

  • Research Site

    NOT_YET_RECRUITING

    Hackensack, New Jersey, 07601, United States

  • Research Site

    NOT_YET_RECRUITING

    Providence, Rhode Island, 02903, United States

  • Research Site

    NOT_YET_RECRUITING

    Darlinghurst, 2010, Australia

  • Research Site

    RECRUITING

    Melbourne, 3000, Australia

  • Research Site

    RECRUITING

    Seoul, 03722, South Korea

  • Research Site

    RECRUITING

    Seoul, 06351, South Korea